On February 3, 2022 Galapagos NV (Euronext & NASDAQ: GLPG) reported that it received a new transparency notification from EcoR1 Capital, LLC (Press release, Galapagos, FEB 3, 2022, View Source [SID1234607790]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 2 February 2022 from EcoR1 Capital LLC, who notified that it holds 3,407,246 of Galapagos’ voting rights, consisting of 211,622 ordinary shares and 3,195,624 American Depository Receipts. EcoR1 Capital LLC, controlled by Mr. Nodelman, controls investment funds EcoR1 Capital Fund Qualified LP and EcoR1 Capital Fund LP, which all together hold 3,407,246 of Galapagos’ voting rights. This represents 5.2% of Galapagos’ currently outstanding 65,552,721 shares. EcoR1 Capital LLC thus crossed above the 5% threshold of Galapagos’ voting rights by acquisition of voting securities on 27 January 2022. The full transparency notice is available on the Galapagos website.